Your browser doesn't support javascript.
loading
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.
Shu, Daniel H; Ho, Won Jin; Kagohara, Luciane T; Girgis, Alexander; Shin, Sarah M; Danilova, Ludmila; Lee, Jae W; Sidiropoulos, Dimitrios N; Mitchell, Sarah; Munjal, Kabeer; Howe, Kathryn; Bendinelli, Kayla J; Qi, Hanfei; Mo, Guanglan; Montagne, Janelle; Leatherman, James M; Lopez-Vidal, Tamara Y; Zhu, Qingfeng; Huff, Amanda L; Yuan, Xuan; Hernandez, Alexei; Coyne, Erin M; Zaidi, Neeha; Zabransky, Daniel J; Engle, Logan L; Ogurtsova, Aleksandra; Baretti, Marina; Laheru, Daniel; Durham, Jennifer N; Wang, Hao; Anders, Robert; Jaffee, Elizabeth M; Fertig, Elana J; Yarchoan, Mark.
Affiliation
  • Shu DH; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Ho WJ; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Kagohara LT; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Girgis A; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Shin SM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Danilova L; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Lee JW; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Sidiropoulos DN; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Mitchell S; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Munjal K; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Howe K; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Bendinelli KJ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Qi H; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Mo G; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Montagne J; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Leatherman JM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Lopez-Vidal TY; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Zhu Q; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Huff AL; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Yuan X; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Hernandez A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Coyne EM; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Zaidi N; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Zabransky DJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Engle LL; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Ogurtsova A; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Baretti M; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Laheru D; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Durham JN; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
  • Wang H; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Anders R; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Jaffee EM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Fertig EJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Yarchoan M; Convergence Institute, Johns Hopkins University, Baltimore, Maryland.
bioRxiv ; 2023 Oct 26.
Article de En | MEDLINE | ID: mdl-37904980
ABSTRACT
Neoadjuvant immunotherapy is thought to produce long-term remissions through induction of antitumor immune responses before removal of the primary tumor. Tertiary lymphoid structures (TLS), germinal center-like structures that can arise within tumors, may contribute to the establishment of immunological memory in this setting, but understanding of their role remains limited. Here, we investigated the contribution of TLS to antitumor immunity in hepatocellular carcinoma (HCC) treated with neoadjuvant immunotherapy. We found that neoadjuvant immunotherapy induced the formation of TLS, which were associated with superior pathologic response, improved relapse free survival, and expansion of the intratumoral T and B cell repertoire. While TLS in viable tumor displayed a highly active mature morphology, in areas of tumor regression we identified an involuted TLS morphology, which was characterized by dispersion of the B cell follicle and persistence of a T cell zone enriched for ongoing antigen presentation and T cell-mature dendritic cell interactions. Involuted TLS showed increased expression of T cell memory markers and expansion of CD8+ cytotoxic and tissue resident memory clonotypes. Collectively, these data reveal the circumstances of TLS dissolution and suggest a functional role for late-stage TLS as sites of T cell memory formation after elimination of viable tumor.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: BioRxiv Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: BioRxiv Année: 2023 Type de document: Article
...